{"id":"https://openalex.org/W3193963636","doi":"https://doi.org/10.1002/cpt.2359","title":"Progress and Challenges in Pharmacogenomics","display_name":"Progress and Challenges in Pharmacogenomics","publication_year":2021,"publication_date":"2021-08-19","ids":{"openalex":"https://openalex.org/W3193963636","doi":"https://doi.org/10.1002/cpt.2359","mag":"3193963636","pmid":"https://pubmed.ncbi.nlm.nih.gov/34412159"},"language":"en","primary_location":{"id":"doi:10.1002/cpt.2359","doi":"https://doi.org/10.1002/cpt.2359","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cpt.2359","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087026299","display_name":"Sara L. Van Driest","orcid":"https://orcid.org/0000-0003-2580-1405","observed_orcids":["https://orcid.org/0000-0003-2580-1405"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara L. Van Driest","raw_affiliation_strings":["Departments of Pediatrics and Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pediatrics and Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059195101","display_name":"Ingolf Cascorbi","orcid":"https://orcid.org/0000-0002-2182-9534","observed_orcids":["https://orcid.org/0000-0002-2182-9534"]},"institutions":[{"id":"https://openalex.org/I4210112713","display_name":"University Hospital Schleswig-Holstein","ror":"https://ror.org/01tvm6f46","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210112713"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Ingolf Cascorbi","raw_affiliation_strings":["Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Germany","institution_ids":["https://openalex.org/I4210112713"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5059195101"],"corresponding_institution_ids":["https://openalex.org/I4210112713"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"110","issue":"3","first_page":"529","last_page":"532"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10261","display_name":"Genetic Associations and Epidemiology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacogenomics","display_name":"pharmacogenomics","score":0.9810000061988831},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.9660000205039978},{"id":"https://openalex.org/keywords/level-of-evidence","display_name":"level of evidence","score":0.6190000176429749},{"id":"https://openalex.org/keywords/clinical-decision-support-systems","display_name":"clinical decision support systems","score":0.6899999976158142},{"id":"https://openalex.org/keywords/economic-incentives","display_name":"economic incentives","score":0.43299999833106995},{"id":"https://openalex.org/keywords/drug-metabolizing-enzymes","display_name":"drug-metabolizing enzymes","score":0.7300000190734863},{"id":"https://openalex.org/keywords/abacavir-hypersensitivity","display_name":"abacavir hypersensitivity","score":0.7480000257492065},{"id":"https://openalex.org/keywords/hla-b-57-01","display_name":"HLA-B*57:01","score":0.9589999914169312},{"id":"https://openalex.org/keywords/pharmgkb","display_name":"PharmGKB","score":0.6579999923706055},{"id":"https://openalex.org/keywords/personalized-medicine","display_name":"personalized medicine","score":0.4180000126361847},{"id":"https://openalex.org/keywords/drug-response-variability","display_name":"drug response variability","score":0.4350000023841858}],"concepts":[{"id":"https://openalex.org/C170734499","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenomics","level":2,"score":0.904504120349884},{"id":"https://openalex.org/C2910701995","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutics","level":5,"score":0.42669227719306946},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42157647013664246},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3582495450973511},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24219077825546265},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19118443131446838},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1173277497291565},{"id":"https://openalex.org/C160492267","wikidata":"https://www.wikidata.org/wiki/Q319616","display_name":"Pharmacognosy","level":4,"score":0.07302817702293396},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010597","descriptor_name":"Pharmacogenetics","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D014644","descriptor_name":"Genetic Variation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D057285","descriptor_name":"Precision Medicine","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/cpt.2359","doi":"https://doi.org/10.1002/cpt.2359","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cpt.2359","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:34412159","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34412159","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Editorial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W3108621279","https://openalex.org/W3138674172","https://openalex.org/W3161514500","https://openalex.org/W3164519145","https://openalex.org/W3165023349","https://openalex.org/W3168682140","https://openalex.org/W3168727558","https://openalex.org/W3169897107","https://openalex.org/W3171350695","https://openalex.org/W3173022441","https://openalex.org/W3173698406","https://openalex.org/W3175801695","https://openalex.org/W3175823386","https://openalex.org/W3180775912","https://openalex.org/W3183219133","https://openalex.org/W7073880321"],"related_works":["https://openalex.org/W2973022862","https://openalex.org/W2521783919","https://openalex.org/W2076143561","https://openalex.org/W2097184538","https://openalex.org/W2102316672","https://openalex.org/W7098776521","https://openalex.org/W7202001943","https://openalex.org/W1508488371","https://openalex.org/W1965934593","https://openalex.org/W4404422001"],"abstract_inverted_index":{"Pharmacogenetics":[0,46,174,298],"has":[1,510,1088],"been":[2,512,531,1090],"widely":[3,50,513],"accepted":[4,51],"as":[5,117,210,335,427,720,816,818,893],"a":[6,341,516,603,638,684,856,919,1085,1099,1190],"crucial":[7],"factor":[8,120],"of":[9,12,24,31,34,55,88,94,115,130,160,202,233,287,292,353,356,366,372,420,433,439,449,473,491,519,526,546,594,607,629,645,655,660,673,679,683,689,699,747,769,792,867,887,922,977,985,1009,1032,1054,1059,1074,1106,1109,1116,1133,1139,1145,1189,1193,1198,1202,1235,1247,1250],"interindividual":[10,1248],"variation":[11,26,596,1111,1249],"drug":[13,163,227,417,440,686,694,826,853,986,1251],"response,":[14],"and":[15,69,79,175,187,275,350,378,389,407,459,497,533,567,623,652,775,790,799,832,897,912,965,982,1036,1039,1061,1077,1103,1155,1253],"there":[16,264,1018,1207],"is":[17,110,126,214,247,265,395,410,725,753,951,1011,1019,1048,1084,1096,1176],"increasing":[18],"information":[19,318,750,1218],"on":[20,173,184,196,260,269,284,296,446,465,489,692,802,828,840,864,936,1159],"the":[21,29,38,44,53,92,113,138,158,231,245,270,285,304,308,336,354,396,404,455,468,471,480,487,495,523,544,570,579,627,633,646,653,671,690,693,697,757,766,829,841,865,996,999,1007,1107,1137,1143,1149,1152,1156,1179,1184,1196,1244],"potential":[22],"influences":[23],"genetic":[25,224,710,749,771,1110],"included":[27],"in":[28,52,121,204,226,332,398,400,424,479,540,543,552,732,743,756,760,788,805,924,941,972,1067,1098,1226,1243],"summary":[30],"product":[32,528],"characteristics":[33],"various":[35,758],"drugs.":[36,234],"Moreover,":[37],"26":[39],"current":[40,456],"guidelines":[41,106,534],"compiled":[42],"by":[43,192,502,555,578,728,895,1015,1101],"Clinical":[45,1236],"Implementation":[47],"Consortium":[48],"are":[49,166,190,221,257,313,535,549,618,703,779,881,902,1208],"community":[54],"clinical":[56,64,75,89,98,278,320,363,392,498,1068,1140,1227],"pharmacologists.":[57],"However,":[58,209,667],"challenges":[59],"remain":[60],"to":[61,72,80,84,104,151,155,223,237,315,346,385,390,414,600,664,709,737,765,784,824,833,846,851,883,953,992,1023,1041,1050,1052,1057,1119,1136,1172,1186,1211,1215,1219,1229,1256],"build":[62,81],"further":[63,625,962,1024],"evidence":[65,95,283,357],"for":[66,100,112,358,609,620,961,980],"additional":[67],"drugs":[68,674,1010],"diverse":[70],"populations,":[71],"develop":[73],"feasible":[74,1220],"decision":[76,499,1069],"support":[77,85,500,1070],"systems,":[78],"economic":[82,463],"incentives":[83],"broad":[86],"implementation":[87,1201,1258],"pharmacogenetics.":[90],"Indeed,":[91],"level":[93,355],"showing":[96],"significant":[97,641],"benefit":[99,286,381],"patients":[101,206,379],"treated":[102],"according":[103],"pharmacogenomics-based":[105],"compared":[107,613],"with":[108,133,199,207,597,614,929,1151],"treatment-as-usual":[109],"decisive":[111],"acceptance":[114],"pharmacogenomics":[116,492],"an":[118],"indispensable":[119],"health":[122,482],"care":[123],"systems.":[124,1071],"It":[125],"understandable":[127],"that":[128,140,312,376,782,870,908,947,957,966,989,1087,1174,1222],"testing":[129],"genes":[131,541,928,1055,1118],"associated":[132,198],"severe":[134],"adverse":[135,162,387],"events":[136,388],"was":[137],"first":[139],"became":[141],"mandatory":[142],"before":[143],"prescription":[144],"(e.g.,":[145,1213],"abacavir-induced":[146],"hypersensitivity":[147,200,238],"being":[148,240,477],"strongly":[149],"linked":[150],"HLA-B*57:01).":[152],"The":[153,290,322,657,844,1046,1072],"attempts":[154],"better":[156],"understand":[157],"mechanisms":[159],"HLA-associated":[161],"reactions,":[164],"however,":[165,1206],"still":[167,1209],"ongoing.":[168],"In":[169,235,252,361,443,575,763,796,932],"this":[170,553,592,661,744,1128,1131],"special":[171],"issue":[172,554,1234],"Pharmacogenomics,":[176],"Deshpande":[177],"et":[178,194,294,327,452,504,557,589,730,809,944],"al.":[179,195,295,328,453,590,731,810,945],"summarize":[180],"highly":[181],"interesting":[182],"insights":[183,1242],"HLA-related":[185],"immunopharmacogenetics,1":[186],"novel":[188,342,927,1241],"data":[189,476,617,1221],"presented":[191],"Liu":[193],"HLA-loci":[197],"reactions":[201,239],"pegaspargase":[203],"pediatric":[205],"leukemia.2":[208],"mentioned":[211],"above,":[212],"it":[213,1175],"all":[215,1177],"about":[216,1178],"evidence.":[217],"Most":[218],"pharmacogenetic":[219,422,466,668,1016],"traits":[220,423,669,711,820],"related":[222],"variants":[225,815,849,923,956],"metabolizing":[228,441],"enzymes":[229],"modulating":[230],"bioavailability":[232],"contrast":[236,764],"essentially":[241],"concentration":[242,695],"independent,":[243],"here,":[244],"question":[246],"not":[248,511,677,717,890,1089],"\"yes\"":[249],"or":[250,429,926,1030],"\"no.\"":[251],"most":[253],"cases,":[254],"dose":[255],"recommendations":[256],"made":[258],"based":[259],"genotype-predicted":[261],"phenotypes.":[262],"Hence,":[263,701],"much":[266,990,1020],"more":[267],"uncertainty":[268],"true":[271],"individual":[272,1231],"metabolic":[273],"activity,":[274],"large":[276,517,920,1001],"randomized":[277],"trials":[279],"could":[280,716,958],"provide":[281,347],"solid":[282],"pharmacogenetics-guided":[288],"therapy.":[289,762],"review":[291,454,801,935],"Luzum":[293],"\"Moving":[297],"Into":[299],"Practice:":[300],"It's":[301],"All":[302],"About":[303],"Evidence!\"":[305],"excellently":[306,726],"outlines":[307,1254],"sometimes":[309],"variable":[310],"requirements":[311],"necessary":[314],"implement":[316],"pharmacogenetics-based":[317],"into":[319,494,751,1204],"care.3":[321],"white":[323],"paper":[324],"from":[325,382,462,564,586,995,1114],"Whirl-Carrillo":[326],"provides":[329],"another":[330],"advancement":[331],"pharmacogenetics":[333,911,1076,1203],"evidence,":[334,1180],"Pharmacogenomics":[337],"Knowledgebase":[338],"(PharmGKB)":[339],"describes":[340],"objective":[343],"scoring":[344],"system":[345],"consistent,":[348],"reproducible,":[349],"transparent":[351],"assessment":[352,976],"variant-drug":[359],"pairs.4":[360],"some":[362],"areas,":[364],"accumulation":[365],"many":[367],"association":[368,520,562,593,642,708,938],"studies":[369,521,907,916,939],"over":[370],"years":[371],"study":[373],"increases":[374],"confidence":[375],"providers":[377],"can":[380,1003,1223],"pharmacogenetic-guided":[383,447,507],"therapy":[384,547,804,839],"avoid":[386,825],"increase":[391],"response.":[393],"This":[394,723,859,1094,1233],"case,":[397],"particular,":[399],"psychiatric":[401],"diseases.":[402],"Here,":[403,878],"successful":[405],"treatment":[406,448,509],"patient's":[408],"adherence":[409],"often":[411],"limited":[412],"due":[413,1022,1040,1056],"inadequate":[415],"active":[416],"concentrations":[418],"because":[419],"unknown":[421,930],"genes,":[425],"such":[426,1027],"CYP2D6":[428],"CYP2C19,":[430],"and/or":[431],"non-consideration":[432],"drug-drug":[434,1078],"interactions":[435],"potentially":[436],"causing":[437],"phenoconversions":[438],"enzymes.":[442],"their":[444,733,797,868,933],"article":[445,488],"depression,":[450],"Zanardi":[451],"real-world":[457],"applications":[458],"challenges.":[460],"Aside":[461],"issues":[464],"testing,":[467],"authors":[469],"outline":[470],"lack":[472],"long-term":[474],"follow-up":[475],"integrated":[478],"electronic":[481],"record":[483],"(EHR)5;":[484],"see":[485],"also":[486,688,863],"integration":[490],"results":[493],"EHR":[496],"systems":[501],"Cook":[503],"al.6":[505],"Similarly,":[506],"antipsychotic":[508],"implemented;":[514],"although":[515],"number":[518],"confirmed":[522,971],"strong":[524],"role":[525],"CYP2D6,":[527],"labels":[529],"have":[530,783,1112],"adapted":[532],"available.":[536],"Further":[537],"promising":[538],"markers":[539],"involved":[542],"pharmacodynamics":[545,672,713],"response":[548,854,1252],"additionally":[550,786],"outlined":[551,946],"Islam":[556],"al.7":[558],"Another":[559],"well-established":[560],"drug-gene":[561],"comes":[563],"high-dose":[565],"simvastatin":[566],"SLCO1B1,":[568],"encoding":[569],"hepatic":[571],"uptake":[572],"transporter":[573],"OATP1B1.":[574],"work":[576],"supported":[577],"Darrell":[580],"Abernethy":[581],"Early":[582],"Stage":[583],"Investigator":[584],"Award":[585],"ASCPT,":[587],"Lu":[588],"extended":[591],"SLCO1B1":[595],"statin-induced":[598],"myotoxicity":[599],"lovastatin,":[601],"presenting":[602],"fourfold":[604],"elevated":[605],"risk":[606],"rhabdomyopathy":[608],"homozygote":[610],"variant":[611],"carriers":[612],"wildtype.":[615],"More":[616],"needed":[619],"atorvastatin.8":[621],"Wendt":[622],"colleagues":[624],"expand":[626],"knowledge":[628,866],"statin":[630],"pharmacogenomics.":[631,914],"Using":[632],"UK":[634],"Biobank,":[635],"they":[636],"observed":[637],"slight":[639],"but":[640,687],"between":[643],"haplotypes":[644],"arylamine":[647],"N-acetyltransferase":[648],"2":[649],"(NAT2)":[650],"gene":[651,777],"use":[654],"simvastatin.":[656],"pharmacological":[658],"background":[659],"finding":[662],"remains":[663,855,991],"be":[665,718,785,822,872,959,970,993,1004,1063,1224],"elucidated.9":[666],"affecting":[670,712],"require":[675],"consideration":[676,1073],"only":[678,1012],"differential":[680],"binding":[681],"properties":[682],"given":[685],"dependency":[691],"at":[696],"site":[698],"action.":[700],"effects":[702],"multifactorial,":[704],"and,":[705],"so":[706,888,1080,1092],"far,":[707],"(despite":[714],"HLA-markers)":[715],"applied":[719,1225],"predictive":[721],"biomarkers.":[722],"problem":[724,1095],"elaborated":[727],"Hertz":[729],"mini-review":[734],"\"Analysis":[735],"Approaches":[736],"Identify":[738],"Pharmacogenetic":[739],"Associations":[740],"With":[741],"Pharmacodynamics\"":[742],"issue.10":[745],"Translation":[746],"complex":[748,1217],"practice":[752],"perfectly":[754],"exemplified":[755],"approaches":[759,1135,1255],"cancer":[761],"above-mentioned":[767],"consequences":[768,886],"hereditary":[770,814],"variants,":[772,892],"somatic":[773,819],"mutations":[774],"altered":[776],"expression":[778,1038],"key":[780],"drivers":[781],"considered":[787,823,1066],"planning":[789],"conductance":[791],"modern":[793],"therapeutic":[794,835],"regimes.":[795],"comprehensive":[798],"timely":[800],"pharmacogenomics-guided":[803],"colon":[806],"cancer,":[807],"Diasio":[808],"demonstrate":[811],"how":[812,1214],"both":[813,1075],"well":[817,1171],"should":[821,1062],"toxicity":[827],"one":[830],"side":[831],"elevate":[834],"efficacy":[836],"through":[837,875,1142],"targeted":[838],"other":[842],"side.11":[843],"extent":[845],"which":[847,1181],"rare":[848],"contribute":[850,1051],"overall":[852],"persistent":[857],"question.":[858],"estimation":[860],"depends":[861],"largely":[862],"functionality":[869],"cannot":[871],"fully":[873],"elucidated":[874],"experimental":[876],"approaches.":[877,1124],"computational":[879,900],"tools":[880],"required":[882,952],"assess":[884],"functional":[885],"far":[889],"characterized":[891],"reviewed":[894],"Zhou":[896],"Lauschke.12":[898],"Such":[899],"methodologies":[901],"particularly":[903],"helpful":[904],"when":[905],"performing":[906],"move":[909,1166,1257],"beyond":[910],"toward":[913],"These":[915],"may":[917],"identify":[918,954],"variety":[921],"known":[925,1049],"functionality.":[931],"systematic":[934],"genomewide":[937,1120],"(GWASs)":[940],"pharmacogenomics,":[942],"McInnes":[943],"subsequent":[948],"fine":[949],"mapping":[950],"causal":[955],"used":[960],"diagnostic":[963],"purposes,":[964],"any":[967],"associations":[968],"must":[969,1182],"external":[973],"cohorts.13":[974],"An":[975],"GWAS":[978],"datasets":[979,1002],"heritability":[981],"genomic":[983],"architecture":[984],"outcomes":[987],"indicated":[988],"learned":[994],"genome,":[997],"provided":[998],"requisite":[1000],"generated.14":[1005],"Finally,":[1006],"pharmacokinetics":[1008],"partly":[1013],"affected":[1014],"traits;":[1017],"variability":[1021],"endogenous":[1025],"factors,":[1026,1043],"organ":[1028],"failure":[1029],"regulation":[1031],"absorption,":[1033],"distribution,":[1034],"metabolism,":[1035],"excretion":[1037],"exogeneous":[1042],"like":[1044],"co-medication.":[1045],"latter":[1047],"phenoconversion":[1053],"inhibition":[1058],"induction":[1060],"therefore":[1064],"routinely":[1065],"interactions,":[1079,1083],"called":[1081],"drug-drug-gene":[1082],"challenge":[1086],"solved":[1091],"far.":[1093],"addressed":[1097],"perspective":[1100],"Bruckmueller":[1102],"Cascorbi.15":[1104],"Studies":[1105],"influence":[1108],"advanced":[1113],"investigations":[1115],"single":[1117],"(and":[1121],"whole":[1122],"genome)":[1123],"Our":[1125],"cover":[1126],"art":[1127],"month":[1129],"features":[1130],"addition":[1132],"pharmacogenomic":[1134],"toolkit":[1138],"pharmacology":[1141],"depiction":[1144],"Manhattan":[1146],"Plots":[1147],"representing":[1148],"cities":[1150],"highest":[1153],"populations":[1154],"tallest":[1157],"buildings":[1158],"every":[1160],"continent":[1161],"(Figure":[1162],"1).":[1163],"As":[1164],"we":[1165,1168],"forward,":[1167],"will":[1169],"do":[1170],"remember":[1173],"span":[1183],"basic":[1185],"translational":[1187],"spectrum":[1188],"wide":[1191],"array":[1192],"therapeutics":[1194],"considering":[1195],"diversity":[1197],"populations.":[1199],"For":[1200],"practice,":[1205],"gaps":[1210],"overcome":[1212],"reduce":[1216],"routine":[1228],"optimize":[1230],"therapy).":[1232],"Pharmacology":[1237],"&":[1238],"Therapeutics":[1239],"gives":[1240],"important":[1245],"field":[1246],"forward.":[1259]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-08-30T00:00:00"}